Real-World AI in Pharma Writing: AuroraPrime Showcased at EMWA 2025
May 08, 2025At the heart of this year’s EMWA Spring Conference in Riga was a shared commitment to advancing medical writing through innovation—and AlphaLife Sciences was proud to be part of the momentum. From dynamic conversations at Booth 1 to a standout session by our Head of AI Product & Strategy, Mike Liang, the spotlight was on how GenAI is reshaping regulatory writing for global pharma. With real-world demos, proven results, and a closer look at our AuroraPrime platform, it was clear: the future of clinical document authoring is already here.
✨ What an incredible time at the EMWA Spring Conference 2025 in Riga! ✨ AlphaLife Sciences was thrilled to participate and connect with the vibrant medical writing community.
A special highlight was our Head of AI Product & Strategy, Mike Liang, presenting his session, "GenAI in Action: Demo and Real-World Case Studies Automating Document Authoring for Regulatory Submissions and Scientific Reports in Top Global Pharma".
During the session, Mike showcased our AuroraPrime AI platform, a trusted solution used by 5 of the top 10 global pharmaceutical companies and leading CROs. Attendees learned how AuroraPrime is transforming regulatory and medical writing with tangible benefits, including:
Significantly reducing first-draft time for critical documents like CSRs and protocols.
Delivering 30–50% overall time savings for CSRs, as validated by top pharma companies.
Mike also introduced AuroraPrime’s powerful AI features, such as our AI-powered templating engine, Automated Quality Check, Versioning, Multimodal Data Ingestion, and No-code application. It was inspiring to see how forward-thinking teams are accelerating timelines and adopting best practices in clinical document creation.
Thank you to everyone who attended Mike's presentation and visited us at Booth 1! 🙏 Your engagement and insights were invaluable.
